Nuvation Bio Inc. (NUVB) vs Recursion Pharmaceuticals, Inc. (RXRX)
Nuvation Bio Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Nuvation Bio Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.1B and $2.0B). Nuvation Bio Inc. grew revenue faster over the last twelve months: 1,083.6% against −15.1%. Nuvation Bio Inc. has the higher net margin (−88.2% vs −945.9%) and the higher return on invested capital (0.00% vs −92.2%). Across the 17 metrics below, Nuvation Bio Inc. leads on 14 and Recursion Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | NUVB | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.18% | 3.48% | 65.16% |
| Operating margin | (81.00%) | (991.72%) | 0.00% |
| Net margin | (88.19%) | (945.92%) | 0.00% |
| Free cash flow margin | (71.17%) | (645.82%) | 0.00% |
| Return on equity | (47.81%) | (56.58%) | (57.72%) |
| Return on assets | (21.53%) | (41.26%) | (49.22%) |
| Return on invested capital | 0.00% | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack